Paper32695101
Neoantigen-Specific Adoptive Cell Therapies for Cancer: Making T-Cell Products More Personal.
Bianchi V and 2 others. Front Immunol, 2020. Cited by 39 papers, by iCite.
Cite this record
ConductScience Library. Neoantigen-Specific Adoptive Cell Therapies for Cancer: Making T-Cell Products More Personal. Papers, record 32695101. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32695101
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Neoantigen-Specific Adoptive Cell Therapies for Cancer: Making T-Cell Products More Personal.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Neoplasm | Major topic |
| Immunotherapy, Adoptive | Major topic |
| T-Cell Antigen Receptor Specificity | Major topic |
| T-Lymphocytes | Major topic |
| Animals | |
| Biomarkers | |
| Cells, Cultured | |
| Clinical Studies as Topic | |
| Coculture Techniques | |
| Cytokines | |
| Epitopes, T-Lymphocyte | |
| HLA Antigens | |
| Humans | |
| Lymphocyte Activation | |
| Lymphocytes, Tumor-Infiltrating | |
| Precision Medicine | |
| Protein Binding | |
| T-Lymphocyte Subsets | |
| Treatment Outcome |
Source PubMed
References133
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30418433 | High-throughput determination of the antigen specificities of T cell receptors in single cells. | Nat Biotechnol | 2018 | https://conductscience.org/library/papers/30418433 | PubMed |
| 2 | 31831802 | One-step artificial antigen presenting cell-based vaccines induce potent effector CD8 T cell responses. | Sci Rep | 2019 | https://conductscience.org/library/papers/31831802 | PubMed |
| 3 | 28628092 | Tissue-resident memory features are linked to the magnitude of cytotoxic T cell responses in human lung cancer. | Nat Immunol | 2017 | https://conductscience.org/library/papers/28628092 | PubMed |
| 4 | 29769722 | Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates. | Nature | 2018 | https://conductscience.org/library/papers/29769722 | PubMed |
| 5 | 15931392 | Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells. | J Clin Invest | 2005 | https://conductscience.org/library/papers/15931392 | PubMed |
| 6 | 29617662 | Driver Fusions and Their Implications in the Development and Treatment of Human Cancers. | Cell Rep | 2018 | https://conductscience.org/library/papers/29617662 | PubMed |
| 7 | 20408898 | MHC class II epitope predictive algorithms. | Immunology | 2010 | https://conductscience.org/library/papers/20408898 | PubMed |
| 8 | 26901407 | Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients. | Nat Med | 2016 | https://conductscience.org/library/papers/26901407 | PubMed |
| 9 | 25304728 | Activation and propagation of tumor-infiltrating lymphocytes on clinical-grade designer artificial antigen-presenting cells for adoptive immunotherapy of melanoma. | J Immunother | 2014 | https://conductscience.org/library/papers/25304728 | PubMed |
| 10 | 28867556 | Neoantigen Vaccines Pass the Immunogenicity Test. | Trends Mol Med | 2017 | https://conductscience.org/library/papers/28867556 | PubMed |
| 11 | 9636188 | Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. | Proc Natl Acad Sci U S A | 1998 | https://conductscience.org/library/papers/9636188 | PubMed |
| 12 | 24048523 | MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemia. | Sci Transl Med | 2013 | https://conductscience.org/library/papers/24048523 | PubMed |
| 13 | 19543285 | Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers. | Nat Methods | 2009 | https://conductscience.org/library/papers/19543285 | PubMed |
| 14 | 31611695 | Predicting HLA class II antigen presentation through integrated deep learning. | Nat Biotechnol | 2019 | https://conductscience.org/library/papers/31611695 | PubMed |
| 15 | 28947567 | 4-1BB Agonist Focuses CD8+ Tumor-Infiltrating T-Cell Growth into a Distinct Repertoire Capable of Tumor Recognition in Pancreatic Cancer. | Clin Cancer Res | 2017 | https://conductscience.org/library/papers/28947567 | PubMed |
| 16 | 25765070 | Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. | Science | 2015 | https://conductscience.org/library/papers/25765070 | PubMed |
| 17 | 29853601 | T-cell Responses to TP53 "Hotspot" Mutations and Unique Neoantigens Expressed by Human Ovarian Cancers. | Clin Cancer Res | 2018 | https://conductscience.org/library/papers/29853601 | PubMed |
| 18 | 22576345 | Tumor-specific CD4+ melanoma tumor-infiltrating lymphocytes. | J Immunother | 2012 | https://conductscience.org/library/papers/22576345 | PubMed |
| 19 | 31011208 | Immunogenic neoantigens derived from gene fusions stimulate T cell responses. | Nat Med | 2019 | https://conductscience.org/library/papers/31011208 | PubMed |
| 20 | 30683863 | Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patients. | Nat Commun | 2019 | https://conductscience.org/library/papers/30683863 | PubMed |
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42461475 | Nonsense-mediated mRNA decay as a gatekeeper of neoantigen expression: Bridging RNA surveillance and tumor immunotherapy. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42461475 | PubMed |
| 42316257 | Cellular immunotherapy in melanoma: the next frontier in cancer treatment. | J Exp Clin Cancer Res | 2026 | https://conductscience.org/library/papers/42316257 | PubMed |
| 42099613 | NeoTCRseek: an integrated platform for high-sensitivity identification of neoantigen-specific TCR clonotypes to track clinical T-cell dynamics. | Front Immunol | 2026 | https://conductscience.org/library/papers/42099613 | PubMed |
| 42027953 | Molecular origin, discovery, validation and application of neoantigens. | Asian J Pharm Sci | 2026 | https://conductscience.org/library/papers/42027953 | PubMed |
| 41740058 | Combination Immunotherapy as a Promising Strategy to Overcome Immunotherapy Resistance: From Emergence to Next-Generation Approaches. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41740058 | PubMed |
| 41669116 | Leveraging T cells for cancer immunotherapy. | Immun Inflamm | 2025 | https://conductscience.org/library/papers/41669116 | PubMed |
| 40574854 | Breaking down physical barriers: strategies to improve lymphocyte infiltration for effective neoantigen-based therapies. | Front Immunol | 2025 | https://conductscience.org/library/papers/40574854 | PubMed |
| 40517350 | Emerging frontiers in adoptive cell therapies: innovations, challenges, and future perspectives. | Med Oncol | 2025 | https://conductscience.org/library/papers/40517350 | PubMed |
| 40165973 | T-cell receptors identified by a personalized antigen-agnostic screening approach target shared neoantigen KRAS Q61H. | Front Immunol | 2025 | https://conductscience.org/library/papers/40165973 | PubMed |
| 39902862 | Isolation of a tumor neoantigen specific CD8+ TCR from a skin biopsy of a vaccination site. | Oncoimmunology | 2025 | https://conductscience.org/library/papers/39902862 | PubMed |
| 39753970 | Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial. | Nat Med | 2025 | https://conductscience.org/library/papers/39753970 | PubMed |
| 39264449 | Recent clinical researches and technological development in TIL therapy. | Cancer Immunol Immunother | 2024 | https://conductscience.org/library/papers/39264449 | PubMed |
| 37700856 | Individualised adjuvant immunotherapy with neoantigen-reactive T cells for gastric signet-ring cell carcinoma. | Clin Transl Immunology | 2023 | https://conductscience.org/library/papers/37700856 | PubMed |
| 37650579 | Groundwork for AI: Enforcing a benchmark for neoantigen prediction in personalized cancer immunotherapy. | Soc Stud Sci | 2023 | https://conductscience.org/library/papers/37650579 | PubMed |
| 37420174 | The use of RNA-based treatments in the field of cancer immunotherapy. | Mol Cancer | 2023 | https://conductscience.org/library/papers/37420174 | PubMed |
| 36569859 | Enhancing CAR T-cell therapies against solid tumors: Mechanisms and reversion of resistance. | Front Immunol | 2022 | https://conductscience.org/library/papers/36569859 | PubMed |
| 36485001 | Tumor-Infiltrating Lymphocyte Therapy in Melanoma: Facts to the Future. | Clin Cancer Res | 2023 | https://conductscience.org/library/papers/36485001 | PubMed |
| 36249685 | Tumor-Infiltrating T Cells Can Be Expanded Successfully from Primary Uveal Melanoma after Separation from Their Tumor Environment. | Ophthalmol Sci | 2022 | https://conductscience.org/library/papers/36249685 | PubMed |
| 35311072 | Cancer Neoantigens: Challenges and Future Directions for Prediction, Prioritization, and Validation. | Front Oncol | 2022 | https://conductscience.org/library/papers/35311072 | PubMed |
| 34707600 | Rapid Identification of the Tumor-Specific Reactive TIL Repertoire via Combined Detection of CD137, TNF, and IFNγ, Following Recognition of Autologous Tumor-Antigens. | Front Immunol | 2021 | https://conductscience.org/library/papers/34707600 | PubMed |
Genes19
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32695101
GET https://conductscience.org/api/papers/v1/32695101/references?page=2